1. A novel in-vitro approach to investigate the molecular interaction between inhaled particles and the human pulmonary surfactant system
- Author
-
Mayville, Bryan
- Subjects
- Biomedical Research, Molecular Biology, Toxicology, In vitro, alveoli, lung surfactants, A549, model development, inhalation toxicology, airborne particulate, PM2.5, diesel particulate, lipidomics
- Abstract
The deployment of military personnel to austere environments poses significant pulmonary health risks from inhalation of particulates including sand, dust, pollution, and heavy machinery exhaust. When particles are less than 10 µm in diameter, they can penetrate deep within the alveoli and embed within the protective lung surfactant monolayer. Here, absorption of surfactant lipids to the particle surface disrupts the essential monolayer configuration needed to reduce surface tension and prevent atelectasis, thus leading to disease. Currently, there are no in vitro surfactant-producing lung cell models capable of studying the effects of inhaled particles on the human pulmonary surfactant system. A549 cells are the most widely used surfactant-producing cells; however, the surfactant is not well characterized, leaving significant gaps in our current understanding. We hypothesize that surfactant produced by A549 cells grown long-term at an air-liquid interface (ALI) will closely mimic that of human surfactant. In addition, we suspect that diesel particulate exposure will result in physiochemical changes in the surfactant that contribute to the development and progression of disease. To explore this, we grew A549 cells long-term at an air-liquid interface establishing a timeline of surfactant production, secretion, and accumulation over time. We discovered a significant increase in surfactant production on day 14 and the presence of a surfactant layer on day 17, suggesting exocytosis into the hypophase at the apical membrane. Investigation of this surfactant layer revealed a diverse pool of lipids that could be used to investigate suspected pulmonary toxicants. However, the composition was noticeably different than that of native human surfactants. Furthermore, we exposed the current model to diesel particulate to study the mechanism driving the molecular interaction between inhaled particles and pulmonary surfactant. Using untargeted lipidomics, we showed a dose-dependent selective absorption consistent with the bulk-phase surfactant composition. A closer look revealed notable homogeneity irrespective of lipid subclass or subspecies. These results significantly advance our understanding of the interaction between diesel particulate and the human pulmonary surfactant system. Additionally, we introduce a novel in vitro method to explore the molecular interaction between other inhaled particles and the human pulmonary surfactant system.
- Published
- 2024